bioMerieux
A global leader in in-vitro diagnostics for over 60 years, bioMérieux is driven by a pioneering spirit and unrelenting commitment to provide innovative diagnostic solutions that improve patient health. Our extensive Antimicrobial Stewardship (AMS) diagnostics range supports appropriate antibiotic use, helping to preserve their efficacy and curb antibiotic resistance. Putting diagnostics at the heart of Antimicrobial Stewardship helps drive informed therapy decisions, providing actionable results to the clinician at every stage of the patient’s healthcare pathway: from initiation of antibiotic therapy to treatment adjustment and optimization and finally for antibiotic discontinuation. We are present in more than 160 countries worldwide.
